iShares U.S. Healthcare ETF (IYH)

Key Metrics

TER 38.00% per year

Distribution policy Distributing

Fund size USD 3,485 M

Inception date June 12, 2000

Holdings 106

Fund currency USD

Fund domicile US

Provider iShares

For full official fund details, factsheets, and holdings, visit ishares.com (opens in new tab).

Historical Return

Last updated: Jun 15, 2026

1 Year +13.9% +1.3% Div

3 Years (avg.) -38.6% +1.3% Div

5 Years (avg.) -24.8% +1.3% Div

Risk & Analysis Metrics

Last updated: Jun 15, 2026

Volatility

14.33% 1 Year

47.31% 3 Years

38.32% 5 Years

30.20% 10 Years

Max Drawdown

-10.92% 1 Year

-82.58% 3 Years

-82.58% 5 Years

-82.58% 10 Years

Sharpe Ratio

0.59 1 Year

-0.51 3 Years

-0.39 5 Years

-0.10 10 Years

Return Triangle (Heatmap)

Last updated: Jun 15, 2026

	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
2011	8.4%	11.9%	19.7%	20.8%	17.2%	13.7%	14.5%	13.0%	13.8%	13.8%	14.6%	12.9%	11.9%	-1.0%	-0.2%
2012		15.4%	25.7%	25.3%	19.5%	14.8%	15.6%	13.6%	14.5%	14.4%	15.3%	13.3%	12.2%	-1.7%	-0.8%
2013			36.9%	30.5%	20.8%	14.6%	15.6%	13.3%	14.4%	14.3%	15.2%	13.1%	12.0%	-3.0%	-1.9%
2014				24.4%	13.5%	8.1%	10.8%	9.1%	11.0%	11.4%	12.8%	10.7%	9.7%	-6.0%	-4.6%
2015					3.6%	0.7%	6.7%	5.6%	8.5%	9.4%	11.2%	9.1%	8.2%	-8.6%	-6.9%
2016						-2.0%	8.2%	6.3%	9.8%	10.6%	12.5%	9.9%	8.8%	-9.8%	-7.9%
2017							19.6%	10.8%	14.1%	14.0%	15.7%	12.0%	10.4%	-10.8%	-8.5%
2018								2.6%	11.4%	12.2%	14.8%	10.6%	9.0%	-14.4%	-11.5%
2019									21.0%	17.3%	19.1%	12.7%	10.3%	-17.0%	-13.4%
2020										13.8%	18.2%	10.0%	7.8%	-23.0%	-18.1%
2021											22.9%	8.2%	5.9%	-30.2%	-23.3%
2022												-4.7%	-1.7%	-42.2%	-31.8%
2023													1.3%	-54.9%	-39.0%
2024														-80.0%	-52.7%
2025															11.6%

Distributions

*by ETF Portfolio Weight Last updated: Jun 15, 2026

Profit Margin Distribution

< 0%

1y 3y N/A N/A

0 - 5%

11%

1y 3y N/A N/A

5 - 10%

14%

1y 3y N/A N/A

10 - 15%

1y 3y N/A N/A

15 - 20%

15%

1y 3y N/A N/A

20 - 30%

25%

1y 3y N/A N/A

30 - 40%

26%

1y 3y N/A N/A

> 40%

1y 3y N/A N/A

P/E Ratio Distribution

< 0

1y 3y N/A N/A

0 - 10

1y 3y N/A N/A

10 - 15

1y 3y N/A N/A

15 - 20

13%

1y 3y N/A N/A

20 - 25

1y 3y N/A N/A

25 - 35

33%

1y 3y N/A N/A

35 - 50

30%

1y 3y N/A N/A

> 50

11%

1y 3y N/A N/A

Discounted Cash Flow

Weighted Average Undervaluation

N/A

Undervalued

> 60%

1y 3y N/A N/A

45 - 60%

1y 3y N/A N/A

30 - 45%

1y 3y N/A N/A

15 - 30%

1y 3y N/A N/A

Fair (±15%)

1y 3y N/A N/A

Overvalued

15 - 30%

1y 3y N/A N/A

30 - 45%

1y 3y N/A N/A

45 - 60%

1y 3y N/A N/A

> 60%

1y 3y N/A N/A

Market Cap Size Distribution

Micro Cap

0.0%

1y 3y N/A N/A

Small Cap

0.1%

1y 3y N/A N/A

Mid Cap

1.9%

1y 3y N/A N/A

Large Cap

54.0%

1y 3y N/A N/A

Mega Cap

44.0%

1y 3y N/A N/A

Micro: < $300M Small: $300M–$2B Mid: $2B–$10B Large: $10B–$200B Mega: > $200B

Average metrics of all companies in portfolio

Last updated: Jun 21, 2026

Market
Average

Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares.	$382B	-
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price.	1.34%	2.03%
Beta Indicates the relationship between the price performance of a share and the market.	0.59	-
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth.	38.12	28.29
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything	-17.75	-
Profitable Companies	98%	-
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued.	28.87	14.56
Price to Sales Ratio Market cap divided by the revenue in the most recent year.	7.23	8.28
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company	12.37	10.72

Market
Average

Enterprise Value to EBIT Enterprise Value divided by EBIT	28.29	21.15
Enterprise Value to Revenue Enterprise value divided by revenue	7.63	8.72
Total Debt to Enterprise Value Total debt divided by enterprise value	0.11	0.05
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary.	1.07	0.33
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability.	19.94%	-6.18%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago.	+23.4%	-117.9%
Return on Equity Equity divided by market cap.	32.55%	1.23%
Return on Assets Indicates a company's profitability in relation to its total assets.	10.48%	3.29%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits.	18.51%	3.31%

Sectors

Manufacturing	61.6%
Finance and Insurance	7.6%
Professional, Scientific, and Technical Services	4.7%
Healthcare	2.4%
Health Care and Social Assistance	1.4%
Wholesale Trade	1.0%
Other	21.3%

Countries

United States	97.0%
Ireland	2.4%
Other	0.3%
United Kingdom	0.2%
Netherlands	0.1%
Other	0.0%

Limit holdings to companies in a single sector.

$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%

Market Cap

P/E Ratio

Total Investment

Weight

Lilly(Eli) & Co

LLY - Manufacturing

Market Cap $1.03T

P/E Ratio 38.9

Dividends 0.6%

Total Investment $498.88M

Weight 14.32%

Loading details…

Johnson & Johnson

JNJ - Manufacturing

Market Cap $549.78B

P/E Ratio 26.5

Dividends 2.3%

Total Investment $328.35M

Weight 9.42%

Loading details…

Abbvie Inc

ABBV - Manufacturing

Market Cap $382.74B

P/E Ratio 106.2

Dividends 3.1%

Total Investment $237.21M

Weight 6.81%

Loading details…

Unitedhealth Group Inc

UNH - Finance and Insurance

Market Cap $364.13B

P/E Ratio 30.3

Dividends 2.2%

Total Investment $156.77M

Weight 4.50%

Loading details…

Thermo Fisher Scientific Inc.

TMO - Professional, Scientific, and Technical Services

Market Cap $172.66B

P/E Ratio 25.2

Dividends 0.4%

Total Investment $131.2M

Weight 3.76%

Loading details…

AMGEN Inc.

AMGN - Manufacturing

Market Cap $182.21B

P/E Ratio 23.3

Dividends 2.9%

Total Investment $110.41M

Weight 3.17%

Loading details…

Intuitive Surgical Inc

ISRG - Manufacturing

Market Cap $144.07B

P/E Ratio 48.6

Dividends 0.0%

Total Investment $106.86M

Weight 3.07%

Loading details…

Gilead Sciences, Inc.

GILD - Manufacturing

Market Cap $153.66B

P/E Ratio 16.7

Dividends 2.6%

Total Investment $106.14M

Weight 3.05%

Loading details…

Boston Scientific Corp.

BSX - Healthcare

Market Cap $175.45B

P/E Ratio 18.9

Dividends 0.0%

Total Investment $82.89M

Weight 2.38%

Loading details…

Danaher Corp.

DHR - Manufacturing

Market Cap $125.4B

P/E Ratio 34.1

Dividends 0.8%

Total Investment $82.76M

Weight 2.37%

Loading details…

Stryker Corp.

SYK - Manufacturing

Market Cap $118B

P/E Ratio 35.3

Dividends 1.1%

Total Investment $76.38M

Weight 2.19%

Loading details…

Vertex Pharmaceuticals, Inc.

VRTX - Manufacturing

Market Cap $114.63B

P/E Ratio 26.5

Dividends 0.0%

Total Investment $72.56M

Weight 2.08%

Loading details…

Bristol-Myers Squibb Co.

BMY - Manufacturing

Market Cap $110.27B

P/E Ratio 15.2

Dividends 4.6%

Total Investment $67.36M

Weight 1.93%

Loading details…

Anthem Inc

ANTM - Finance and Insurance

Market Cap $114.59B

P/E Ratio 16.5

Dividends 1.8%

Total Investment $46.15M

Weight 1.32%

Loading details…

Regeneron Pharmaceuticals, Inc.

REGN - Manufacturing

Market Cap $62.84B

P/E Ratio 14.3

Dividends 0.6%

Total Investment $45.17M

Weight 1.30%

Loading details…

Cigna Group (The)

CI - Finance and Insurance

Market Cap $73.88B

P/E Ratio 11.8

Dividends 2.2%

Total Investment $43.36M

Weight 1.24%

Loading details…

Becton Dickinson & Co.

BDX - Manufacturing

Market Cap $52.16B

P/E Ratio 36.5

Dividends 2.6%

Total Investment $34.95M

Weight 1.00%

Loading details…

Zoetis Inc - Ordinary Shares - Class A

ZTS - Manufacturing

Market Cap $33B

P/E Ratio 12.6

Dividends 2.6%

Total Investment $33.45M

Weight 0.96%

Loading details…

Idexx Laboratories, Inc.

IDXX - Manufacturing

Market Cap $44.34B

P/E Ratio 41.1

Dividends 0.0%

Total Investment $32.07M

Weight 0.92%

Loading details…

Cardinal Health, Inc.

CAH - Wholesale Trade

Market Cap $51.94B

P/E Ratio 33.8

Dividends 0.9%

Total Investment $30.8M

Weight 0.88%

Loading details…

Key Metrics

Compare similar ETFs

Historical Return

Risk & Analysis Metrics

Volatility

Max Drawdown

Sharpe Ratio

Return Triangle (Heatmap)

Distributions

Profit Margin Distribution

P/E Ratio Distribution

Discounted Cash Flow

Market Cap Size Distribution

Portfolio Concentration

Latest News

AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis

Why AbbVie Stock Jumped Today

AbbVie's $10.9 Billion Apogee Deal Will Extend Its Immunology Dominance: Is It Time to Load Up on This Dividend King?

Average metrics of all companies in portfolio

Sectors

Countries

Stock Screener

Lilly(Eli) & Co

Lilly(Eli) & Co

Johnson & Johnson

Johnson & Johnson

Abbvie Inc

Abbvie Inc

Unitedhealth Group Inc

Unitedhealth Group Inc

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc.

AMGEN Inc.

AMGEN Inc.

Intuitive Surgical Inc

Intuitive Surgical Inc

Gilead Sciences, Inc.

Gilead Sciences, Inc.

Boston Scientific Corp.

Boston Scientific Corp.

Danaher Corp.

Danaher Corp.

Stryker Corp.

Stryker Corp.

Vertex Pharmaceuticals, Inc.

Vertex Pharmaceuticals, Inc.

Bristol-Myers Squibb Co.

Bristol-Myers Squibb Co.

Anthem Inc

Anthem Inc

Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc.

Cigna Group (The)

Cigna Group (The)

Becton Dickinson & Co.

Becton Dickinson & Co.

Zoetis Inc - Ordinary Shares - Class A

Zoetis Inc - Ordinary Shares - Class A

Idexx Laboratories, Inc.

Idexx Laboratories, Inc.

Cardinal Health, Inc.

Cardinal Health, Inc.

Cookie Settings